BNTC

Benitec Biopharma Inc. is a biotechnology company operating in the healthcare sector with 19 employees and a market capitalization of $402.62 million. The company's financial health indicates significant losses, with net income totaling -$41,823,000 and EBITDA at -$45,723,000 over the trailing twelve months. The gross margin, operating margin, and profit margin are all at 0.0%, suggesting that costs may be a major concern for the business. The company has substantial cash reserves of $94.48 million but also carries debt worth $817,000. Return on Equity (ROE) is -53.0% and Return on Assets (ROA) is -34.7%, indicating significant difficulties in generating returns from assets. The valuation context is characterized by a negative forward P/E ratio of -1.26 and an EV/EBITDA of -7.27, suggesting that the market may be pricing in expectations for future improvement or changes to the company's financial performance. The price to book ratio is 3.33, indicating some multiple expansion compared to tangible book value. Dividend information is not available due to a payout ratio of 0.0%.